Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Pfizer CEO Albert Bourla says an oral drug the company is developing to treat COVID-19 symptoms could be available to the public by the end of the year. “If all goes well, and we implement the same speed that we are,